People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other Health Care, Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cytrellis Biosystems, Inc. | — | Other Health Care | Series C | $82.7M | $182.1M | 2020 |
| Quanterix Corp | — | Other Technology | Series C | $71.8M | $194.1M | 2010 |
| Permeon Biologics, Inc. | — | Pharmaceuticals | Seed | $6.0M | $95.1M | 2010 |
Keith L. Crandell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Keith L. Crandell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Connolly | 1 | 14 |
| Paul Meister | 1 | 12 |
| Keith Crandell | 1 | 11 |
| John Edwards | 1 | 8 |
| John M. Connolly | 1 | 6 |
| David Walt | 1 | 6 |
| David R. Walt | 1 | 5 |
| John McDonough | 1 | 5 |
| Diane Marcou | 1 | 5 |
| Douglas Cole | 1 | 5 |
| Marijn Dekkers | 1 | 4 |
| Michael L Peterson | 1 | 4 |
| PAUL M MEISTER | 1 | 4 |
| David Okrongly | 1 | 4 |
| R. ROX ANDERSON | 1 | 3 |
| Martin Madaus | 1 | 3 |
| Paul Chapman | 1 | 3 |
| Keith A. Crandall | 1 | 2 |
| John A. McDonough | 1 | 2 |
| Kevin Hrusovsky | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.